Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Marisiensis - Seria Medica
Volume 66 (2020): Issue 1 (March 2020)
Open Access
The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects
Monica Oroian
Monica Oroian
,
Diana Ioana Pop
Diana Ioana Pop
,
Ana-Maria Gheldiu
Ana-Maria Gheldiu
,
Sandeep Bhardwaj
Sandeep Bhardwaj
,
Adriana Marcovici
Adriana Marcovici
,
Arshad Khuroo
Arshad Khuroo
and
Laurian Vlase
Laurian Vlase
| Mar 31, 2020
Acta Marisiensis - Seria Medica
Volume 66 (2020): Issue 1 (March 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Mar 31, 2020
Page range:
30 - 34
Received:
Aug 01, 2019
Accepted:
Jan 29, 2020
DOI:
https://doi.org/10.2478/amma-2020-0006
Keywords
dapagliflozin
,
bioequivalence trial
,
Caucasian subjects
,
fasted state
© 2020 Monica Oroian et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.